| 摘要 |
<p>The invention provides the use of an alpha3 adrenoceptor antagonist for the manufacture of an ophthalmic composition for potentiating the intraocular pressure-lowering activity of an alpha2 adrenoceptor agonist co-administered therewith. The invention also provides an ophthalmic composition containing an alpha3 adrenoceptor antagonist and an alpha2 adrenoceptor agonist, and an ophthalmically acceptable carrier therefor.</p> |
